Danletro
Danletro 2.5mg Tablet
Letrozole
Drug Identity
Active Ingredient
Letrozole
What is Danletro?
Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...
How to Take It
Dosage information not available for this product.
Safety Alerts
Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed
Important Warnings
Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing
Side Effects
The most common side effects of Monjuvi when given with lenalidomide in DLBCL are: respiratory tract infection feeling tired or weak diarrhea cough fever swelling of the lower legs or hands decreased appetite infusion-related reactions. The most common side effects of Monjuvi when given with lenalidomide and rituximab in FL are: respiratory tract infections diarrhea rash feeling tired or weak muscle and bone pain constipation cough infusion-related reactions.
Drug Interactions
Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.
Price Intelligence
Rs 4,931.75
DRAP approved maximum price · per pack of 10 · approved 22 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 10Rs 4,931.75
Should you consider an alternative?
Other options containing Letrozole, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Hitase
2.5mg
Rs 1,900Rs 190/unit
Lowest price per unitBelow approved ceilingNo DRAP alerts
Retzole
2.5Mg
Rs 1,995Rs 199.5/unit
Below approved ceilingPHARMEVO PRIVATE LIMITED.
LETOCOR
2.5MG
Rs 2,270.5Rs 227.05/unit
Below approved ceilingHIGH-Q INTERNATIONAL.
Estrolet
2.5Mg
Rs 2,375Rs 237.5/unit
Below approved ceilingNABIQASIM INDUSTRIES
Lets
2.5mg
Rs 3,135Rs 313.5/unit
Below approved ceilingNo DRAP alertsGENIX PHARMA PRIVATE LIMITED
Senora
2.5mg
Rs 1,025
Below approved ceilingNo DRAP alertsSCOTMANN PHARMACEUTICALS
Letara
2.5mg
Rs 1,700
Below approved ceilingAJ Mirza Pharma Pvt Ltd
Sliczole
2.5mg
Rs 2,000
Below approved ceilingNo DRAP alertsGENOME PHARMACEUTICALS (PVT) LTD
Pronco
2.5mg
Rs 3,501
Below approved ceilingNo DRAP alertsMcOlson Research Laboratories Pvt. Ltd
Letrasan
2.5mg
Rs 3,666
Below approved ceilingThe Searle Company Limited
Lettrozone
2.5mg
Rs 3,700.21
No DRAP alertsPharmedic Laboratories (Pvt.) Ltd Lahore
Letaraeachfilmcoated
2.5mg
Rs 3,805.5
No DRAP alertsAJ Mirza Pharma Pvt Ltd DSL: 235
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
95
brands
69
molecules
0
alerts